ID   TL-1
AC   CVCL_B371
SY   TL1
DR   CLO; CLO_0050020
DR   BioSample; SAMN03472078
DR   DepMap; ACH-002055
DR   RCB; RCB1871
DR   TKG; TKG 0607
DR   Wikidata; Q54972597
RX   PubMed=2486610;
RX   PubMed=6268866;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~36 hours (PubMed=2486610; PubMed=6268866).
CC   Sequence variation: Mutation; HGNC; 5362; ID3; Simple; p.Glu53Ter (c.157G>T); Zygosity=Heterozygous (DepMap).
CC   Sequence variation: Mutation; HGNC; 7672; NCOR1; Simple; p.Ile1927fs (c.5779_5780delAT); Zygosity=Heterozygous (DepMap).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr236Ser (c.707A>C); ClinVar=VCV000182966; Zygosity=Homozygous (DepMap).
CC   Derived from site: In situ; Ileocecal lymph node; UBERON=UBERON_8480054.
ST   Source(s): RCB; TKG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 16
//
RX   PubMed=2486610;
RA   Yaoita S., Ohoi R., Hayashi Y., Watanabe T.;
RT   "Establishment and characterization of TL-1 cell line from a ileo-cecal
RT   Burkitt's lymphoma.";
RL   Hum. Cell 2:197-197(1989).
//
RX   PubMed=6268866;
RA   Hayashi Y., Matsumura Y., Nishihira T., Watanabe I., Ohi R., Kasai M.,
RA   Kumagai K., Kamada N.;
RT   "Burkitt's lymphoma cell line bearing surface IgA and negative for
RT   nuclear antigen of Epstein-Barr virus (EBNA).";
RL   Jpn. J. Exp. Med. 50:423-434(1980).
//